脊柱和骶骨附件的原发性恶性骨和软组织肿瘤。

IF 2.8 Q1 ORTHOPEDICS
Eleonora Schneider, Thomas M Tiefenboeck, Christoph Böhler, Iris-Melanie Noebauer-Huhmann, Susanna Lang, Petra Krepler, Philipp T Funovics, Reinhard Windhager
{"title":"脊柱和骶骨附件的原发性恶性骨和软组织肿瘤。","authors":"Eleonora Schneider, Thomas M Tiefenboeck, Christoph Böhler, Iris-Melanie Noebauer-Huhmann, Susanna Lang, Petra Krepler, Philipp T Funovics, Reinhard Windhager","doi":"10.1302/2633-1462.62.BJO-2024-0169.R1","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>The aim of the present study was to analyze the oncological and neurological outcome of patients undergoing interdisciplinary treatment for primary malignant bone and soft-tissue tumours of the spine within the last seven decades, and changes over time.</p><p><strong>Methods: </strong>We retrospectively analyzed our single-centre experience of prospectively collected data by querying our tumour registry (Medical University of Vienna). Therapeutic, pathological, and demographic variables were examined. Descriptive data are reported for the entire cohort. Kaplan-Meier analysis and multivariate Cox regression analysis were applied to evaluate survival rates and the influence of potential risk factors.</p><p><strong>Results: </strong>A total of 119 consecutive patients (mean age 38 years (SD 37; 1 to 83), mean follow-up 66 months (SD 26; 0 to 505) were investigated. Histological entities included Ewing's sarcoma (EWS; 33), chondrosarcoma (CSA; 20), osteosarcoma (OSA; 22), and soft-tissue sarcoma (STS; 44). Surgery was performed in 88 patients (74%). Neurological parameters improved in 18 patients (20%) after surgery. Overall, 32 patients (36%) suffered from surgical complications requiring revision. The median survival was 42 months (IQR 10 to 204). The one-, five-, and ten-year survival rates were 73%, 47%, and 39%, respectively. Corresponding five-year survival rates for EWS, CSA, OSA, and STS were 63%, 61%, 40%, and 32%, respectively. The decade of diagnosis, histological entity, surgical intervention, resection margin, and the presence of metastases had significant influence on survival. (Neo-)adjuvant therapies alone had no significant influence on overall survival.</p><p><strong>Conclusion: </strong>Our study clearly demonstrates the positive impact of improved surgical techniques, as well as refined imaging methods and evolved adjuvant therapy options, on survival rate in all tumour entities. However, despite a multimodal treatment plan, the long-term mortality of these tumours remains high.</p>","PeriodicalId":34103,"journal":{"name":"Bone & Joint Open","volume":"6 2","pages":"109-118"},"PeriodicalIF":2.8000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11785419/pdf/","citationCount":"0","resultStr":"{\"title\":\"Primary malignant bone and soft-tissue tumours of the spine and appendicular sacrum.\",\"authors\":\"Eleonora Schneider, Thomas M Tiefenboeck, Christoph Böhler, Iris-Melanie Noebauer-Huhmann, Susanna Lang, Petra Krepler, Philipp T Funovics, Reinhard Windhager\",\"doi\":\"10.1302/2633-1462.62.BJO-2024-0169.R1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>The aim of the present study was to analyze the oncological and neurological outcome of patients undergoing interdisciplinary treatment for primary malignant bone and soft-tissue tumours of the spine within the last seven decades, and changes over time.</p><p><strong>Methods: </strong>We retrospectively analyzed our single-centre experience of prospectively collected data by querying our tumour registry (Medical University of Vienna). Therapeutic, pathological, and demographic variables were examined. Descriptive data are reported for the entire cohort. Kaplan-Meier analysis and multivariate Cox regression analysis were applied to evaluate survival rates and the influence of potential risk factors.</p><p><strong>Results: </strong>A total of 119 consecutive patients (mean age 38 years (SD 37; 1 to 83), mean follow-up 66 months (SD 26; 0 to 505) were investigated. Histological entities included Ewing's sarcoma (EWS; 33), chondrosarcoma (CSA; 20), osteosarcoma (OSA; 22), and soft-tissue sarcoma (STS; 44). Surgery was performed in 88 patients (74%). Neurological parameters improved in 18 patients (20%) after surgery. Overall, 32 patients (36%) suffered from surgical complications requiring revision. The median survival was 42 months (IQR 10 to 204). The one-, five-, and ten-year survival rates were 73%, 47%, and 39%, respectively. Corresponding five-year survival rates for EWS, CSA, OSA, and STS were 63%, 61%, 40%, and 32%, respectively. The decade of diagnosis, histological entity, surgical intervention, resection margin, and the presence of metastases had significant influence on survival. (Neo-)adjuvant therapies alone had no significant influence on overall survival.</p><p><strong>Conclusion: </strong>Our study clearly demonstrates the positive impact of improved surgical techniques, as well as refined imaging methods and evolved adjuvant therapy options, on survival rate in all tumour entities. However, despite a multimodal treatment plan, the long-term mortality of these tumours remains high.</p>\",\"PeriodicalId\":34103,\"journal\":{\"name\":\"Bone & Joint Open\",\"volume\":\"6 2\",\"pages\":\"109-118\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11785419/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bone & Joint Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1302/2633-1462.62.BJO-2024-0169.R1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone & Joint Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1302/2633-1462.62.BJO-2024-0169.R1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究的目的是分析在过去的70年里,因脊柱原发性恶性骨和软组织肿瘤而接受跨学科治疗的患者的肿瘤学和神经学结果,以及随时间的变化。方法:通过查询我们的肿瘤登记处(维也纳医科大学),我们回顾性地分析了前瞻性收集数据的单中心经验。检查了治疗、病理和人口统计学变量。报告了整个队列的描述性数据。采用Kaplan-Meier分析和多因素Cox回归分析评估生存率及潜在危险因素的影响。结果:共119例患者(平均年龄38岁,SD 37;1 ~ 83),平均随访66个月(SD 26;0 ~ 505例)。组织学实体包括尤文氏肉瘤(EWS);33),软骨肉瘤(CSA;20),骨肉瘤(OSA;22)和软组织肉瘤(STS;44)。88例(74%)患者接受手术治疗。术后18例(20%)患者神经系统参数改善。总的来说,32名患者(36%)遭受手术并发症需要翻修。中位生存期为42个月(IQR 10 - 204)。1年、5年和10年生存率分别为73%、47%和39%。EWS、CSA、OSA和STS相应的5年生存率分别为63%、61%、40%和32%。诊断时间、组织学实体、手术干预、切除边缘和转移灶的存在对生存率有显著影响。单纯(新)辅助治疗对总生存率无显著影响。结论:我们的研究清楚地表明,改进的手术技术、改进的成像方法和改进的辅助治疗方案对所有肿瘤实体的生存率都有积极的影响。然而,尽管有多种治疗方案,这些肿瘤的长期死亡率仍然很高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Primary malignant bone and soft-tissue tumours of the spine and appendicular sacrum.

Aims: The aim of the present study was to analyze the oncological and neurological outcome of patients undergoing interdisciplinary treatment for primary malignant bone and soft-tissue tumours of the spine within the last seven decades, and changes over time.

Methods: We retrospectively analyzed our single-centre experience of prospectively collected data by querying our tumour registry (Medical University of Vienna). Therapeutic, pathological, and demographic variables were examined. Descriptive data are reported for the entire cohort. Kaplan-Meier analysis and multivariate Cox regression analysis were applied to evaluate survival rates and the influence of potential risk factors.

Results: A total of 119 consecutive patients (mean age 38 years (SD 37; 1 to 83), mean follow-up 66 months (SD 26; 0 to 505) were investigated. Histological entities included Ewing's sarcoma (EWS; 33), chondrosarcoma (CSA; 20), osteosarcoma (OSA; 22), and soft-tissue sarcoma (STS; 44). Surgery was performed in 88 patients (74%). Neurological parameters improved in 18 patients (20%) after surgery. Overall, 32 patients (36%) suffered from surgical complications requiring revision. The median survival was 42 months (IQR 10 to 204). The one-, five-, and ten-year survival rates were 73%, 47%, and 39%, respectively. Corresponding five-year survival rates for EWS, CSA, OSA, and STS were 63%, 61%, 40%, and 32%, respectively. The decade of diagnosis, histological entity, surgical intervention, resection margin, and the presence of metastases had significant influence on survival. (Neo-)adjuvant therapies alone had no significant influence on overall survival.

Conclusion: Our study clearly demonstrates the positive impact of improved surgical techniques, as well as refined imaging methods and evolved adjuvant therapy options, on survival rate in all tumour entities. However, despite a multimodal treatment plan, the long-term mortality of these tumours remains high.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Bone & Joint Open
Bone & Joint Open ORTHOPEDICS-
CiteScore
5.10
自引率
0.00%
发文量
0
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信